DCF — NEWTON MEDICAL CENTER
Enterprise Value: $-213.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-213.4M
Enterprise Value
$-69.6M
PV of Cash Flows
$-143.8M
PV of Terminal Value
$-231.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $195.0M | $-12.2M | -6.0% | $-20.4M | $-18.6M |
| Year 2 | $200.9M | $-10.5M | -5.0% | $-19.0M | $-15.7M |
| Year 3 | $206.9M | $-8.8M | -4.0% | $-17.5M | $-13.2M |
| Year 4 | $213.1M | $-8.0M | -4.0% | $-17.0M | $-11.6M |
| Year 5 | $219.5M | $-7.7M | -3.0% | $-16.9M | $-10.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-213.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$189.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.06737917703882107
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5